LVMH Moët Hennessy - Louis Vuitton Société Européenne (MOH)
XETRA Stock Exchange · Germany · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 388.05 |
|---|---|
| 52-week range | 375.70 – 654.00 |
| Return, 1 month / 3 months | −3.5% / −18.3% |
| Return, 1 year / 3 years | −35.8% / −37.5% |
| Trend | Below its 200-day average |
| RSI (14) | 42 |
| Volatility (1 year) | 27.0% |
| Worst drawdown (1 year) | -41.0% |
| Average daily value traded | 1.92M EUR |
| Dividend yield | 3.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
LVMH Moët Hennessy - Louis Vuitton Société Européenne is a French luxury goods group based in Paris. It designs and sells fashion and leather goods, wines and spirits, perfumes and cosmetics, watches and jewellery, and selective retailing through brands such as Louis Vuitton, Dior, Moët & Chandon, Hennessy, Bulgari and Sephora. Its customers are affluent shoppers and travellers worldwide, served through its own boutiques, department stores and specialist retail chains.
The shares are listed on the XETRA Stock Exchange in Germany under the code MOH, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
LVMH Moët Hennessy - Louis Vuitton Société Européenne (MOH) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 388.05 on 22 October 2026.
Its price-based Market X-Ray is 43 out of 100 (a weak price profile), ranking 459 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 35.8% and over the last three months it fell 18.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 20 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -18.1% | ||
| From 52-week high | -40.5% | ||
| Momentum | 19 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -18.3% | ||
| 6-month return | -16.8% | ||
| 12-month return, skipping the last month | -33.5% | ||
| Stability (higher is calmer) | 53 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 27.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -41.0% | ||
| Liquidity | 79 · Strong | Trades actively. | |
| Average daily value traded | 1.92M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 78 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 3.4% | ||
| Years with dividends | 6 |
Strengths
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −2.6% |
|---|---|
| 1 month | −3.5% |
| 3 months | −18.3% |
| 6 months | −16.8% |
| 1 year | −35.8% |
| 3 years | −37.5% |
| 5 years | −36.0% |
Signals
| 50-day / 200-day average | 413.73 / 473.69 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 7.89 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 28 Apr 2026 | EUR 7.5000 |
| 2 Dec 2025 | EUR 5.5000 |
| 24 Apr 2025 | EUR 7.5000 |
| 2 Dec 2024 | EUR 5.5000 |
| 23 Apr 2024 | EUR 7.5000 |
| 4 Dec 2023 | EUR 5.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.